Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-human Study of ATX-898, as Monotherapy and in Combination With Other Anti-neoplastic Agents, in Participants With Advanced Solid Tumors

NCT07767474 is registered in ClinicalTrials.gov with Antares Therapeutics, Inc as lead sponsor.

NCT NCT07767474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07767474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-human Study of ATX-898, as Monotherapy and in Combination With Other Anti-neoplastic Agents, in Participants With Advanced Solid Tumors
Lead sponsor
Antares Therapeutics, Inc
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
January 31, 2030
Enrollment
343 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors